Cargando…
Anti-Interferon Auto-Antibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
Levin discusses a new study, by Meager and colleagues, which identified a novel target of the disordered immune response in patients with APS-1.
Autor principal: | Levin, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475656/ https://www.ncbi.nlm.nih.gov/pubmed/16756392 http://dx.doi.org/10.1371/journal.pmed.0030292 |
Ejemplares similares
-
Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Meager, Anthony, et al.
Publicado: (2006) -
Autoimmune thyroiditis - track towards autoimmune polyendocrinopathy type III
por: Hodé, Annelie Kérékou, et al.
Publicado: (2021) -
Reversible adrenal insufficiency and heterophile antibodies in a case of autoimmune polyendocrinopathy syndrome
por: Kharb, Sandeep, et al.
Publicado: (2013) -
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
por: Ferré, Elise M. N., et al.
Publicado: (2021) -
Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome
por: Besnard, Marine, et al.
Publicado: (2022)